381 related articles for article (PubMed ID: 30860204)
21. Natriuretic Peptides and the Management of Heart Failure.
Kern T; Kedan I; Kimchi A
Rev Cardiovasc Med; 2015; 16(2):95-104. PubMed ID: 26198556
[TBL] [Abstract][Full Text] [Related]
22. Recent advances in point-of-care testing for natriuretic peptides: potential impact on heart failure diagnosis and management.
Iwaz JA; Maisel AS
Expert Rev Mol Diagn; 2016 Jun; 16(6):641-50. PubMed ID: 26919295
[TBL] [Abstract][Full Text] [Related]
23. The Current and Potential Clinical Relevance of Heart Failure Biomarkers.
Gandhi PU; Testani JM; Ahmad T
Curr Heart Fail Rep; 2015 Oct; 12(5):318-27. PubMed ID: 26280466
[TBL] [Abstract][Full Text] [Related]
24. The potential role of natriuretic peptide-guided management for patients hospitalized for heart failure.
Maisel A; Xue Y; Greene SJ; Pang PS; Januzzi JL; Piña IL; DeFilippi C; Butler J
J Card Fail; 2015 Mar; 21(3):233-9. PubMed ID: 25433362
[TBL] [Abstract][Full Text] [Related]
25. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology.
Paulus WJ; Tschöpe C; Sanderson JE; Rusconi C; Flachskampf FA; Rademakers FE; Marino P; Smiseth OA; De Keulenaer G; Leite-Moreira AF; Borbély A; Edes I; Handoko ML; Heymans S; Pezzali N; Pieske B; Dickstein K; Fraser AG; Brutsaert DL
Eur Heart J; 2007 Oct; 28(20):2539-50. PubMed ID: 17428822
[TBL] [Abstract][Full Text] [Related]
26. Clinical utility of biomarkers in chronic kidney disease and chronic heart failure.
Zachariah D; Olechowski B; Kalra PR
J Ren Care; 2013 Sep; 39(3):128-39. PubMed ID: 23902278
[TBL] [Abstract][Full Text] [Related]
27. Natriuretic peptide testing for heart failure therapy guidance in the inpatient and outpatient setting.
Green SM; Green JA; Januzzi JL
Am J Ther; 2009; 16(2):171-7. PubMed ID: 19300043
[TBL] [Abstract][Full Text] [Related]
28. [Natriuretic peptides--when should they be used in heart failure?].
Rottlaender D; Michels G; Hoppe UC
Dtsch Med Wochenschr; 2008 Feb; 133(5):196-200. PubMed ID: 18213553
[TBL] [Abstract][Full Text] [Related]
29. [Natriuretic peptides for the management of patients with heart failure: a bridge between primary care and cardiology?].
D'Ambrosio G; Parretti D; De Maria R; Cricelli I; Di Tano G; Aspromonte N
G Ital Cardiol (Rome); 2016 Jan; 17(1):41-7. PubMed ID: 26901257
[TBL] [Abstract][Full Text] [Related]
30. Natriuretic peptides in heart failure: where we are, where we are going.
Palazzuoli A; Antonelli G; Quatrini I; Nuti R
Intern Emerg Med; 2011 Feb; 6(1):63-8. PubMed ID: 20853071
[TBL] [Abstract][Full Text] [Related]
31. [Sequential Natriuretic Peptide Measurements to Monitor Treatment and Prognosis During Heart Failure Therapy].
Becher MU
Dtsch Med Wochenschr; 2020 Apr; 145(7):458-463. PubMed ID: 32236926
[TBL] [Abstract][Full Text] [Related]
32. [Natriuretic peptides in heart failure].
Nguyen Trung ML; Tridetti J; Ancion A; Oury C; Lancellotti P
Rev Med Liege; 2020 Oct; 75(10):644-648. PubMed ID: 33030839
[TBL] [Abstract][Full Text] [Related]
33. Clinical findings, natriuretic peptides, and echocardiography: integrating tools to optimize heart failure management.
Beck-da-Silva L; Rohde LE; Goldraich L; Clausell N
Congest Heart Fail; 2007; 13(3):158-63. PubMed ID: 17541310
[TBL] [Abstract][Full Text] [Related]
34. Biomarkers in heart failure: a focus on natriuretic peptides.
Eltayeb M; Squire I; Sze S
Heart; 2024 May; 110(11):809-818. PubMed ID: 37673654
[TBL] [Abstract][Full Text] [Related]
35. Role of natriuretic peptides in heart failure patients with special reference to those on cardiac resynchronization therapy.
Ricciardi G; Pieragnoli P; Colella A; Giaccardi M; Padeletti L; Abbate R; Gensini GF; Michelucci A
Minerva Cardioangiol; 2006 Dec; 54(6):743-52. PubMed ID: 17167386
[TBL] [Abstract][Full Text] [Related]
36. [Place of natriuretic peptides in the early diagnosis of heart failure in community medicine].
Galinier M; Cariou E; Lairez O; Fournier P; Delmas C; Biendel-Picquet C; Roncalli J
Presse Med; 2018 Sep; 47(9):804-810. PubMed ID: 30293850
[TBL] [Abstract][Full Text] [Related]
37. [Role of biomarkers for risk stratification in the tailored follow-up of heart failure patients].
Aspromonte N; Di Tano G; Latini R; Masson S; Valle R; Emdin M
G Ital Cardiol (Rome); 2010 May; 11(5 Suppl 2):17S-23S. PubMed ID: 20873464
[TBL] [Abstract][Full Text] [Related]
38. Natriuretic peptide testing in emergency settings.
Ordonez-Llanos J; Merce-Muntanola J; Santalo-Bel M
Clin Chem Lab Med; 2008; 46(11):1543-9. PubMed ID: 19012518
[TBL] [Abstract][Full Text] [Related]
39. Natriuretic Peptides and Analytical Barriers.
Vasile VC; Jaffe AS
Clin Chem; 2017 Jan; 63(1):50-58. PubMed ID: 28062611
[TBL] [Abstract][Full Text] [Related]
40. The role of natriuretic peptides in heart failure.
de Sa DD; Chen HH
Curr Cardiol Rep; 2008 May; 10(3):182-9. PubMed ID: 18489861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
